T1rz is a synthetic dual-agonist research peptide with affinity for the GIP and GLP-1 receptors. It is supplied for in-vitro investigation of incretin receptor signalling, and is not for human or veterinary use.
Mechanistic focus
- Investigated in dual receptor signalling pathways (GLP-1 and GIP)
- Explored in studies involving metabolic system interaction
- Studied for its role in multi-pathway endocrine modulation
Research applications
- Dual receptor signalling models
- Metabolic and endocrine interaction systems
- Peptide-based regulatory pathways
Handling & specification
Supplied as a lyophilised powder in a sealed vial, strength as labelled. Store lyophilised material cold and away from light; once reconstituted with bacteriostatic water, keep refrigerated and protected from light. Reconstitution volume is determined by the researcher according to the experimental protocol.
Purity & documentation
Every batch is supplied with batch-specific Certificate of Analysis (COA) documentation where applicable, accessible via the QR code on the vial label or through our COA Verification page. Use the product name and batch/lot number on the vial to locate the relevant records.
Despatched from the UK with tracked delivery.
For research purposes only. Not for human or veterinary use. Sold to qualified researchers and institutions for in-vitro laboratory research only.
